DrugPatentWatch Database Preview
Wockhardt Bio Ag Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for WOCKHARDT BIO AG, and what generic and branded alternatives to WOCKHARDT BIO AG drugs are available?
WOCKHARDT BIO AG has fifty-eight approved drugs.
Summary for Wockhardt Bio Ag
| US Patents: | 0 |
| Tradenames: | 52 |
| Ingredients: | 50 |
| NDAs: | 58 |
| Drug Master File Entries: | 10 |
| PTAB Cases with Wockhardt Bio Ag as petitioner: | See PTAB cases with Wockhardt Bio Ag as petitioner |
Drugs and US Patents for Wockhardt Bio Ag
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wockhardt Bio Ag | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 208429-001 | Jan 17, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Wockhardt Bio Ag | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065420-001 | Dec 2, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Wockhardt Bio Ag | CLEMASTINE FUMARATE | clemastine fumarate | SYRUP;ORAL | 074863-001 | Mar 13, 1998 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
